Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
phosphorylase kinase regulatory subunit alpha 1 | 0.839 | 0.115 | 2.1E-07 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
phosphorylase kinase regulatory subunit alpha 1 | 0.839 | 0.115 | 2.1E-07 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 1989 | 1989 | ||||||||
|
angiotensin II receptor associated protein | 0.890 | 0.115 | 0.19 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
angiotensin II receptor associated protein | 0.890 | 0.115 | 0.19 |
|
group | 0.210 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
potassium voltage-gated channel subfamily A member regulatory beta subunit 1 | 0.821 | 0.115 | 4.2E-02 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
uridine-cytidine kinase 1 | 0.839 | 0.115 | 1.0E-05 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
uridine-cytidine kinase 1 | 0.839 | 0.115 | 1.0E-05 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
actin related protein 2/3 complex subunit 3 | 0.839 | 0.154 | 0.22 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
gap junction protein delta 3 | 0.890 | 0.154 | 3.3E-05 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
ankyrin repeat domain 23 | 0.861 | 0.154 | 3.5E-19 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
N-acyl phosphatidylethanolamine phospholipase D | 0.861 | 0.154 | 2.9E-05 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
FERM and PDZ domain containing 1 | 0.805 | 0.154 | 2.2E-12 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
F-box protein 10 | 0.861 | 0.154 | 2.4E-06 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
staufen double-stranded RNA binding protein 2 | 0.890 | 0.154 | 0.97 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
cell death inducing DFFA like effector b | 0.861 | 0.154 | 8.2E-15 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
cell death inducing DFFA like effector b | 0.861 | 0.154 | 8.2E-15 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
cell death inducing DFFA like effector b | 0.861 | 0.154 | 8.2E-15 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
cell death inducing DFFA like effector b | 0.861 | 0.154 | 8.2E-15 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
CGRP receptor component | 0.821 | 0.154 | 9.0E-07 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
CGRP receptor component | 0.821 | 0.154 | 9.0E-07 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
adhesion molecule with Ig like domain 3 | 0.890 | 0.154 | 2.1E-04 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
adhesion molecule with Ig like domain 3 | 0.890 | 0.154 | 2.1E-04 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
regulated endocrine specific protein 18 | 0.931 | 0.154 | 8.7E-10 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
regulated endocrine specific protein 18 | 0.931 | 0.154 | 8.7E-10 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
protein phosphatase 1 catalytic subunit gamma | 0.861 | 0.154 | 0.96 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2016 | 2018 |